Koutsofta Ioanna, Mamais Ioannis, Chrysostomou Stavri
a Department of Life Sciences , European University Cyprus , Nicosia, Cyprus.
b Department of Hygiene, Epidemiology and Medical Statistics, Medical School , National and Kapodistrian University of Athens , Athens, Greece.
J Women Aging. 2019 Mar-Apr;31(2):117-139. doi: 10.1080/08952841.2018.1418822. Epub 2018 Jan 10.
The main objective of this systematic review was to examine the effectiveness of protein supplementation through diet or dietary supplements on osteoporosis in postmenopausal women as evidenced by randomized controlled trials (RCTs). Five RCTs were included using dietary protein (N = 2), protein supplements (N = 2), and proteins through diet and supplements (N = 1). A total of 677 postmenopausal woman were included, all diagnosed with osteoporosis (T score < -2.5) and aged between 50 and 80 years. Results have found that combined protein administration through diet, mainly from animal sources and supplemental proteins (whey proteins, 86 g/d PRO including 6 g WPI), for a short period of time (up to 12 months) may positively affect osteoporosis in postmenopausal women. In addition, a positive effect can also be achieved by the single administration of a 250 mg/d supplement in which 10 g was WPI for a six-month period. In this review, it is shown that both combined administration of proteins through diet and supplements and single administration through protein supplements may reduce the risk of fracture in postmenopausal osteoporotic women. In contrast, dietary proteins alone, in doses similar to and/or higher than the RDA values, may not have any positive effect on treating osteoporosis.
本系统评价的主要目的是通过随机对照试验(RCT)来检验通过饮食或膳食补充剂补充蛋白质对绝经后女性骨质疏松症的有效性。纳入了5项RCT,其中2项使用膳食蛋白质,2项使用蛋白质补充剂,1项使用饮食和补充剂中的蛋白质。总共纳入了677名绝经后女性,她们均被诊断为骨质疏松症(T值<-2.5),年龄在50至80岁之间。结果发现,短期内(长达12个月)通过饮食联合补充蛋白质,主要是动物来源的蛋白质和补充蛋白质(乳清蛋白,每日86克蛋白质,包括6克乳清分离蛋白),可能对绝经后女性的骨质疏松症产生积极影响。此外,在6个月内每日单次服用250毫克补充剂(其中10克为乳清分离蛋白)也可产生积极效果。本评价表明,通过饮食和补充剂联合补充蛋白质以及通过蛋白质补充剂单次补充蛋白质,均可降低绝经后骨质疏松症女性的骨折风险。相比之下,仅摄入与推荐膳食摄入量(RDA)值相似和/或更高剂量的膳食蛋白质,可能对治疗骨质疏松症没有任何积极作用。